ArticlePDF Available

Manual immature reticulocyte fraction; a surrogate marker to assess post traumatic blood loss

Authors:
  • Faculty of Medicine University of Ruhuna

Abstract and Figures

Introduction: Erythropoietic response following chemotherapy and stem cell transplant is assessed by reticulocytosis and immature reticulocyte fraction (IRF). They are not used to assess erythropoiesis following acute haemorrhage even though it is known to cause reticulocytosis. This study was performed to evaluate the use of IRF as a marker of degree of post-traumatic haemorrhage. Methods: A cross sectional descriptive study was performed using routine anticoagulated blood samples collected from patients admitted with acute traumatic haemorrhage to an emergency treatment unit. Differential and total reticulocyte counts were performed manually using standard techniques with bright field microscopy. The data on severity of blood loss were extracted from clinical records. Results: There were total of 38 patients. Mean IRF of patients with mild (n = 14), moderate (n = 19) and severe (n = 05) haemorrhage were 1.86 ± 1.0%, 3.26 ± 1.8% and 10.2 ± 3.6% respectively. Mean manual IRF of group with severe haemorrhage was significantly higher than those of all the others (p = 0.000). The mean manual IRF of moderate haemorrhage group was significantly higher than that of mild group (p = 0.01). Manual IRF and severity of haemorrhage were significantly positively correlated (r = 0.71, p < 0.01, n = 38). Immature reticulocytes of stage I was observed only in patients with severe haemorrhage. Conclusion: The manual IRF can be used as a reliable marker of severity of post-traumatic acute haemorrhage.
Content may be subject to copyright.
Original article
158
Galle Medical Journal, Vol 26: No. 4, December 2021
Manual immature reticulocyte fraction; a surrogate marker to assess
post traumatic blood loss
1 2 3
Wickramaratne KAC , Wijegunawardena JKD , Wijewickrama DC
1 3
Department of Pathology, Department of Physiology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.
2Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka.
Correspondence: Dr. Chandana Wickramaratne
e-mail: kacw@med.ruh.ac.lk
https://orcid.org/0000-0003-4394-2535
Submitted on 24.10.2021 and accepted for publication on 04.12.2021
ABSTRACT
Introduction: Erythropoietic response following chemotherapy and stem cell transplant is assessed by
reticulocytosis and immature reticulocyte fraction (IRF). They are not used to assess erythropoiesis following
acute haemorrhage even though it is known to cause reticulocytosis. This study was performed to evaluate the
use of IRF as a marker of degree of post-traumatic haemorrhage.
Methods: A cross sectional descriptive study was performed using routine anticoagulated blood samples
collected from patients admitted with acute traumatic haemorrhage to an emergency treatment unit. Differential
and total reticulocyte counts were performed manually using standard techniques with bright field microscopy.
The data on severity of blood loss were extracted from clinical records.
Results: There were total of 38 patients. Mean IRF of patients with mild (n = 14), moderate (n = 19) and
severe (n = 05) haemorrhage were 1.86 ± 1.0%, 3.26 ± 1.8% and 10.2 ± 3.6% respectively. Mean manual IRF of
group with severe haemorrhage was significantly higher than those of all the others (p = 0.000). The mean
manual IRF of moderate haemorrhage group was significantly higher than that of mild group (p = 0.01). Manual
IRF and severity of haemorrhage were significantly positively correlated (r = 0.71, p < 0.01, n = 38). Immature
reticulocytes of stage I was observed only in patients with severe haemorrhage.
Conclusion: The manual IRF can be used as a reliable marker of severity of post-traumatic acute haemorrhage.
Keywords: Acute haemorrhage, surrogate marker, immature reticulocyte fraction, post-traumatic blood loss,
Reticulocytes, manual immature reticulocyte fraction.
Introduction
Post traumatic haemorrhage needs prompt medical
attention as it can cause significant morbidity
and mortality due to acute hypovolaemia and
shock (1). Degree of blood loss is classified based
on clinical assessment in acute trauma care.
Following haemorrhage, erythropoiesis is increased
in the marrow and more immature forms of red
cells (reticulocytes) are rapidly released in to the
peripheral circulation. Reticulocytes can be
classified based on their maturation using both
manual and automated techniques (2-4). The
immature reticulocyte fraction (IRF), is a novel
parameter available in fully automated haematology
analysers. It is used as an early indicator of marrow
erythropoietic activity in stress conditions and
to assess marrow response following therapy or
stem cell transplant (5-7). Automated IRF is
prohibitively costly to use in routine care in limited
resource settings (8-10).
DOI: http://doi.org/10.4038/gmj.v26i4.8112
Original article
159
Galle Medical Journal, Vol 26: No. 4, December 2021
Manual reticulocyte counting is performed in
many limited resource laboratories but manual IRF
calculation is not. Therefore, this study was carried
out to evaluate the possibility of using manual
IRF in assessing the degree of haemorrhage in acute
trauma.
Methods
All the patients admitted to an emergency treatment
unit (ETU) of a Teaching Hospital during a period of
one month, with post-traumatic acute haemorrhage
irrespective of the degree of haemorrhage were
recruited to the study. Informed written consent
was taken from the patient when he or she was in
a position to do so and when they were unable to
consent, assent was obtained from a guardian or
relative. Those who had known clinical conditions
that could directly affect haematological results
were excluded from the study.
Clinical assessment of severity of blood loss on
admission and the time taken for admission since
traumatic event were extracted from patient
records which were maintained by acute trauma
physicians.
Venous blood samples (5 ml) collected from
antecubital fossa using standard techniques
{in to tubes containing Dipotassium Ethyle-
-nediaminetetraacetic acid (K2EDTA)} were used
to prepare blood smears to perform reticulocyte
counting. Blood smears were prepared within one
hour of collection of samples and reticulocyte
staining was performed using standard supra vital
staining procedure (9, 10). The quality of the stain
was verified by the presence of stained platelets
and white cells in each smear and it was considered
the positive control. The differential count of
immature reticulocytes and total reticulocyte count
were performed manually using bright field
microscope (X100 power/ oil immersion in
Olympus CX 32) fitted with an ocular graticule.
The IRF (stage I and II reticulocytes) was calculated
as a percentage of all the reticulocytes counted.
Reticulocytes were classified as per the Heilmeier
classification (Figure 1) and the differential count
of each stage of reticulocytes was performed (4). The
reticulocyte counting and manual IRF calculations
were performed in duplicates by the researchers.
A difference of 10% or less in the duplicate
counts was considered acceptable. Reticulocyte
percentages of all the patients were monitored
hourly for four to five hours.
Data were analysed using MS-Excel 2010 and
R-Studio statistical software. According to the
clinical assessment on the patients’ records the
subjects were grouped in to mild, moderate and
severe blood loss. The differences between groups
were assessed using student’s t-Test. The correlation
was assessed with Spearman correlation coefficient.
p < 0.05 was considered significant.
Ethics approval was obtained from the Ethical
Review Committee of Faculty of Allied Health
Sciences, University of Ruhuna, Sri Lanka.
Institutional permission and approval was obtained
to retrieve data and to conduct the research in the
emergency trauma unit, which was mandatory to
the obtain ethical clearance.
Results
There were total of 38 patients who fulfilled the
inclusion criteria and of them 24 (63.1%) were
males and 14 (36.8%) were females. Of the total,
14 had mild, 19 had moderate and five had severe
acute post traumatic haemorrhage. The median age
of the study group was 36 years.
The mean manual IRF were 1.86 ± 1.0%, 3.26 ±
1.8% and 10.2 ± 3.6% in patients with mild,
moderate and severe haemorrhage respectively.
The mean manual IRF of patients with severe
haemorrhage was significantly higher than those
of all the other patients with haemorrhage (mild
and moderate) (p = <0.001). The mean manual
IRF of patients with moderate haemorrhage was
also significantly higher than that of the patients
with mild haemorrhage (p = 0.01). The manual
IRF and the severity of haemorrhage were
significantly positively correlated (r = .71, p < 0.01,
n = 38) (Figure 2).
All four stages of reticulocytes were observed in
patients with severe haemorrhage while only stages
II, III and IV were observed in mild and moderate
haemorrhages (Figure 3).
Original article
160
Galle Medical Journal, Vol 26: No. 4, December 2021
Stage I Stage II
Stage III Stage IV
Figure 1: Maturation stages of reticulocytes according to Heilmeier classification. Stage I: non-nucleated
red cells appearing with a dense clumped reticulum; Stage II: extended network of loose
reticulum; Stage III; scattered granules with residual reticulum network; Stage IV: scattered
granules
Figure 2: Correlation of immature reticulocyte fraction (IRF) and severity of haemorrhage
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
1hr 2hrs 3hrs 4hrs
Mild
Stage 2
Stage 3
Stage 4
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
1hr 2hrs 5hrs
Severe
Stage 1
Stage 2
Stage 3
Stage 4
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
1hr 2hrs 3hrs 4hrs
Moderate
Stage 1
Stage 2
Stage 3
Stage 4
Reticulocyte %
Reticulocyte %
Reticulocyte %
Figure 3: Percentages of reticulocyte stages and time duration since trauma in mild,
moderate and severe haemorrhages and their trend lines
Discussion
Assessment of trauma-related blood loss is
subjective and is supported mainly by clinical
criteria (1). The subjective nature of this assessment
is improved by the use of non-laboratory parameters
such as blood pressure, pulse rate, pulse pressure,
urine output and level of consciousness. The
assessment of haemorrhagic shock is aided by
laboratory parameters such as complete blood count
and arterial blood gas analysis (10-14). Yet, accurate
estimation of blood loss is subjective and
challenging.
The automated IRF is considered one of the best
parameters to detect early marrow response
following chemotherapy or stem cell transplant
(1-8). The data on use of automated or manual IRF
to assess degree of haemorrhage in routine trauma
care is not found in literature.
The peripheral blood reticulocyte count of healthy
adults is 1% - 2%. All the reticulocytes in peripheral
blood of healthy individuals belong to Heilmeier
stages III and IV and are considered the mature
forms (4, 8, 9). The reticulocytes stages I and II
(immature forms) are not normally found in
peripheral circulation of healthy individuals (15).
In this study, both stages I and II of immature
reticulocytes were seen in peripheral blood of all
the patients with severe haemorrhage. The patients
with mild and moderate haemorrhage showed
only the stage II of immature reticulocytes.
Therefore, increased IRF (both stages I & II) in
peripheral blood appears to be an objective marker
which differentiate severe haemorrhage from mild
and moderate. Increased IRF of only stage II could
be considered a marker of mild and moderate
Original article
161
Galle Medical Journal, Vol 26: No. 4, December 2021
haemorrhage. In addition, stage IV reticulocytes
showed progressive decline over five hours of study
period in all the patients with severe haemorrhage.
None of the acute blood loss assessment tools
have incorporated either automated or manual IRF
for estimation of blood loss. The findings of this
study show the value of estimation of either
manual or possibly automated IRF as an objective
surrogate indicator of degree of haemorrhage.
Since, patients with moderate and severe bleeding
are inevitably managed with crystalloids and/or
blood transfusions; one can argue the reliability of
IRF following an intervention. The details of
standard care given to the patients before collection
of blood samples for IRF were not collected in
this study. However, irrespective of whether volume
expanders were given or not, the patients with
moderate and severe haemorrhages showed high
IRF proving its applicability in detecting the degree
of post traumatic acute haemorrhage. In addition,
decrement of percentages of mature forms (stage IV)
and increment of immature forms (stages I and II)
appeared to be unique for severe haemorrhage.
Further studies are needed to assess the effects of
volume resuscitation and other comorbid factors
on IRF in post-traumatic acute haemorrhage and
to demonstrate the reliability of IRF in estimation
of degree of haemorrhage in non-traumatic or
trauma related concealed (retroperitoneal, intra-
abdominal or intra muscular) haemorrhage.
Limitations
This study was carried out using manual method
available for reticulocyte counting and it has its
own limitations related to distribution of cells in
smear, counting procedure and the limited number
of cells counted. If the automated method was
used, highly accurate and precise information on
reticulocytes could have been obtained as large
number of cells are counted in that method thus,
it would have provided more accurate objective
information on the relationship between IRF and
the degree of acute blood loss in trauma. In this
study, the grading of blood loss was performed
by acute care physicians and surgeons and not by
the researchers. If a universal grading scale for
classifying degree of blood loss was incorporated
in the assessment of blood loss, highly standardized
information could have been gathered.
Manual IRF and progressive increment of IRF while
decrement of percentages of mature reticulocytes
reliably indicate severity of post traumatic acute
haemorrhage and would be potentially useful even
in assessment of acute concealed haemorrhage.
Acknowledgements
We acknowledge the administrative team of
emergency treatment unit, Teaching Hospital,
Karapitiya, Galle, Sri Lanka and staff of Medical
Laboratory Science Department of Faculty of Allied
Health Sciences for the provision of laboratory
facilities to conduct this research project.
Competing Interests:
The authors have no competing interests.
Funding:
Authors received no funding from any institution
or organization to carry out this study.
References
1. Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D,
Hunt BJ, et al. The European guideline on management of
major bleeding and coagulopathy following trauma: Fifth
edition. Critical Care (London, England). 2019; 23(1): 98.
2. Piva E, Brugnara C, Spolaore F, Plebani M. Clinical
utility of reticulocyte parameters. Clinics in Laboratory
Medicine. 2015; 35(1): 133-163.
3. Molina JR, Sanchez-Garcia J, Torres A, Alvarez MA,
Serrano J, Casaño J, et al. Reticulocyte maturation
parameters are reliable early predictors of hematopoietic
engraftment after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation: Journal
of the American Society for Blood and Marrow
Transplantation. 2007; 13(2): 172-182.
4. Koepke JF, Koepke JA. Reticulocytes. Clinical and
Laboratory Haematology. 1986; 8(3): 169-179.
Original article
162
Galle Medical Journal, Vol 26: No. 4, December 2021
5. Morkis IV, Farias MG, Rigoni LD, Scotti L, Gregianin
LJ, Daudt LE, et al. Assessment of immature platelet
fraction and immature reticulocyte fraction as predictors of
engraftment after haematopoietic stem cell transplantation.
International Journal of Laboratory Haematology. 2015;
37(2): 259-264.
6. Md Noor, Sabariah and Leong, Cooi Fun, Cheong SK.
Immature reticulocyte fraction in guiding stem cell harvest
in autologous peripheral blood stem cell transplant.
Malaysian Journal of Medicine and Health Sciences.
2014; 10: 1-6.
7. Raja-Sabudin RZ, Othman A, Ahmed-Mohamed KA,
Ithnin A, Alauddin H, Alias H, et al. Immature reticulocyte
fraction is an early predictor of bone marrow recovery
post chemotherapy in patients with acute leukemia.
Saudi Medical Journal. 2014; 35(4): 346-349.
8. Buttarello M, Bulian P, Farina G, Petris MG, Temporin V,
Toffolo L. Five fully automated methods for performing
immature reticulocyte fraction: comparison in diagnosis
of bone marrow aplasia. American Journal of Clinical
Pathology. 2002; 117(6): 871-879.
9. Bain BJ, Bates I, Laffan MA. Dacie and Lewis Practical
Haematology E-Book: Elsevier Health Sciences; 2016.
10. World Health Organization. Health Laboratory T,
Bl ood Safety U , Internatio nal Commit tee for
Standardization in Haematology. Expert Panel in C.
ICSH guidelines for reticulocyte counting by microscopy
on supravitally stained preparations/ prepared on behalf
of the World Health Organization by the Expert Panel
on Cytometry of the International Council for
Standardization in Haematology. Geneva: World Health
Organization; 1992.
11. Figueiredo S, Taconet C, Harrois A, Hamada S, Gauss T,
Raux M, et al. How useful are haemoglobin concentration
and its variations to predict significant haemorrhage in
the early phase of trauma? A multicentric cohort study.
Annals of Intensive Care. 2018; 8(1): 76.
12. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical
review: haemorrhagic shock. Critical Care (London,
England). 2004; 8(5): 373-381.’
13. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ,
Pendry K. A practical guideline for the haematological
management of major haemorrhage. British Journal of
Haematology. 2015; 170(6): 788-803.
14. Kauvar DS, Lefering R, Wade CE. Impact of haemorrhage
on trauma outcome: an overview of epidemiology,
clinical presentations, and therapeutic considerations.
The Journal of Trauma. 2006; 60(6 Suppl): S3-11.
15. Crouch JY, Kaplow LS. Relationship of reticulocyte age
to polychromasia, shift cells, and shift reticulocytes.
Archives of Pathology & Laboratory Medicine. 1985;
109(4): 325-329.
Original article
163
Galle Medical Journal, Vol 26: No. 4, December 2021
... Maturation stages of reticulocytes according to Heilmeier classification [9]. DOI: http://dx.doi.org/10.5772/intechopen.1006826 ...
Chapter
Full-text available
Reticulocytes, immature red blood cells, are crucial for assessing erythropoiesis and bone marrow function, offering insights into various hematological conditions. This abstract highlights their clinical significance in evaluating red blood cell production, diagnosing, prognosis, and monitoring treatments. Reticulocyte counts reflect the rate of erythropoiesis in response to physiological or pathological changes, aiding in the assessment of bone marrow function and oxygen delivery capacity. Elevated reticulocyte counts indicate a compensatory response to anemia, while decreased counts suggest impaired erythropoiesis or bone marrow issues. Reticulocyte indices, such as the reticulocyte production index (RPI) and corrected reticulocyte count, provide further insights into erythropoietic dynamics, helping distinguish between hypo- and hyperproliferative conditions. These parameters are also valuable in diagnosing and managing disorders such as hemolytic anemias, bone marrow failures, and myelodysplastic syndromes, as well as in monitoring treatment efficacy. Changes in reticulocyte counts post-treatment, such as with erythropoietin therapy or blood transfusions, offer feedback on therapeutic effectiveness and guide patient care. Overall, reticulocytes are essential for diagnosing, classifying, and managing hematological conditions, improving patient outcomes and care quality.
Article
The development of hematologic analyzers allowed us to assess several additional parameters derived in addition to the number of reticulocytes. There is, among others, the calculation of immature reticulocyte fractions, reticulocyte maturity index, reticulocyte production index, and equivalent reticulocyte hemoglobin. The advantage of the equivalent hemoglobin and the content of hemoglobin is the insensitivity to interference by inflammation. These newly introduced parameters expand the possibilities to access bone marrow erythropoietic activity, iron stores, and the effectiveness of iron supplementation, vitamin B12, and folic acid supplementation. These parameters are also used to make decisions about blood transfusions or to detect occult internal bleeding.
Article
Full-text available
Background Severe traumatic injury continues to present challenges to healthcare systems around the world, and post-traumatic bleeding remains a leading cause of potentially preventable death among injured patients. Now in its fifth edition, this document aims to provide guidance on the management of major bleeding and coagulopathy following traumatic injury and encourages adaptation of the guiding principles described here to individual institutional circumstances and resources. Methods The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma was founded in 2004, and the current author group included representatives of six relevant European professional societies. The group applied a structured, evidence-based consensus approach to address scientific queries that served as the basis for each recommendation and supporting rationale. Expert opinion and current clinical practice were also considered, particularly in areas in which randomised clinical trials have not or cannot be performed. Existing recommendations were re-examined and revised based on scientific evidence that has emerged since the previous edition and observed shifts in clinical practice. New recommendations were formulated to reflect current clinical concerns and areas in which new research data have been generated. Results Advances in our understanding of the pathophysiology of post-traumatic coagulopathy have supported improved management strategies, including evidence that early, individualised goal-directed treatment improves the outcome of severely injured patients. The overall organisation of the current guideline has been designed to reflect the clinical decision-making process along the patient pathway in an approximate temporal sequence. Recommendations are grouped behind the rationale for key decision points, which are patient- or problem-oriented rather than related to specific treatment modalities. While these recommendations provide guidance for the diagnosis and treatment of major bleeding and coagulopathy, emerging evidence supports the author group’s belief that the greatest outcome improvement can be achieved through education and the establishment of and adherence to local clinical management algorithms. Conclusions A multidisciplinary approach and adherence to evidence-based guidance are key to improving patient outcomes. If incorporated into local practice, these clinical practice guidelines have the potential to ensure a uniform standard of care across Europe and beyond and better outcomes for the severely bleeding trauma patient. Electronic supplementary material The online version of this article (10.1186/s13054-019-2347-3) contains supplementary material, which is available to authorized users.
Article
Full-text available
Background: The diagnostic value of hemoglobin (Hb) for detecting a significant hemorrhage (SH) in the early phase of trauma remains controversial. The present study aimed to assess the abilities of Hb measurements taken at different times throughout trauma management to identify patients with SH. Methods: All consecutive adult trauma patients directly admitted to six French level-1 trauma centers with at least one prehospital Hb measurement were analyzed. The abilities of the following variables to identify SH (≥ 4 units of red blood cells in the first 6 h and/or death related to uncontrolled bleeding within 24 h) were determined and compared to that of shock index (SI): Hb as measured with a point-of-care (POC) device by the prehospital team on scene (POC-Hbprehosp) and upon patient's admission to the hospital (POC-Hbhosp), the difference between POC-Hbhosp and POC-Hbprehosp (DeltaPOC-Hb) and Hb as measured by the hospital laboratory on admission (Hb-Labhosp). Results: A total of 6402 patients were included, 755 with SH and 5647 controls (CL). POC-Hbprehosp significantly predicted SH with an area under ROC curve (AUC) of 0.72 and best cutoff values of 12 g/dl for women and 13 g/dl for men. POC-Hbprehosp < 12 g/dl had 90% specificity to predict of SH. POC-Hbhosp and Hb-Labhosp (AUCs of 0.92 and 0.89, respectively) predicted SH better than SI (AUC = 0.77, p < 0.001); best cutoff values of POC-Hbhosp were 10 g/dl for women and 12 g/dl for men. DeltaPOC-Hb also predicted SH with an AUC of 0.77, a best cutoff value of - 2 g/dl irrespective of the gender. For a same prehospital fluid volume infused, DeltaPOC-Hb was significantly larger in patients with significant hemorrhage than in controls. Conclusions: Challenging the classical idea that early Hb measurement is not meaningful in predicting SH, POC-Hbprehosp was able, albeit modestly, to predict significant hemorrhage. POC-Hbhosp had a greater ability to predict SH when compared to shock index. For a given prehospital fluid volume infused, the magnitude of the Hb drop was significantly higher in patients with significant hemorrhage than in controls.
Article
Full-text available
Peripheral blood (PB) CD34+ cells enumeration is currently the most reliable method to guide the timing of stem cell harvest. However, its usage is restricted by being technically challenging, costly, and time-consuming. Immature reticulocyte fraction (IRF) determination, which is simpler and cheaper and has a faster turn-around time, has been proposed for a similar purpose. The purpose of this study is to evaluate the value of IRF in guiding stem cell harvest and examine the correlation between IRF and PB CD34+ cells count. Daily pre-harvest tests, i.e. PB CD34+ cells and IRF from 21 patients scheduled for autologous PBSC transplant were assessed. Stem cells harvests were commenced when the PB CD34+ cell count were more than 10 cell/ul. A total of 205 pre-harvest tests were analysed. Following stem cell mobilisations, both the IRF and PB CD 34+ cell counts rose with a variable pattern. In this study, we observed that the IRF peaks preceded the PB CD34+ count by 2 days. On the day of stem cell harvest, all the peak IRF values were >0.3. The PB CD34+ cell counts correlated with the harvested stem cell yield, whereby r2 = 0.77, p < 0.021. In autologous stem cell mobilisation, we believe that IRF is a useful screening tool to predict the rise of the PB CD34+ cell counts as it is a simple, fast and less costly. An IRF of > 0.3 may be used as a cut-off value for the initiation of PB CD34+ quantification prior to stem cell harvest.
Article
Full-text available
The reticulocyte count reflects the erythropoietic activity of bone marrow and is thus useful in both diagnosing anemias and monitoring bone marrow response to therapy. Automated flow-cytometric analysis has led to a significant advance in reticulocyte counting, by simultaneously providing additional parameters and indices such as the reticulocyte immature reticulocyte fraction (IRF), the reticulocyte volume, and the hemoglobin content and concentration. IRF has been proposed as an early marker of engraftment. Reticulocyte hemoglobin content is useful in assessing the functional iron available for erythropoiesis, and reticulocyte volume is a useful indicator when monitoring the therapeutic response of anemias. Copyright © 2015 Elsevier Inc. All rights reserved.
Article
Full-text available
IntroductionEngraftment is a critical milestone of the hematopoietic stem cell transplantation (HSCT) process. The immature platelet fraction (IPF) and immature reticulocyte fraction (IRF) are considered early indicators of bone marrow recovery. The objective of this study was to assess these parameters as predictors of HSCT engraftment.Methods Neutrophil and platelet engraftment were defined as the first of three consecutive days with an absolute neutrophil count >0.5 × 109/L or platelet count >20 × 109/L, respectively. The IRF cutoff was 12%. Two IPF cutoffs were used: >6.2% and >10%.ResultsThe study sample comprised 44 patients, of whom 24 had undergone autologous HSCT and 20 had undergone allogeneic HSCT. Absolute neutrophil counts >0.5 × 109/L were preceded by IRF >12% in 86% of patients (38 of 44). Platelet counts >20 × 109/L were preceded by an IPF >6.2% in 90% of patients (37 of 41) and by an IPF >10% in 63% of patients (26 of 41).Conclusion The results show that IRF and IPF are engraftment predictors. Peak in IPF was observed before rise in platelet count, while IRF rises before absolute neutrophil count (ANC) and persists increased. This indicates that IRF and IPF can be considered as new tools for hematopoietic assessment after HSCT.
Article
Full-text available
We performed a parallel evaluation of 5 automated reticulocyte counters to produce the immature reticulocyte fraction (IRF). We analyzed 225 samples from healthy control subjects, 115 from patients with various diseases, 38 with advanced aplasia, and 22 in early erythropoietic recovery after chemotherapy or bone marrow transplantation. The reference intervals were different for each instrument (ADVIA 120, 0.04-0.25; CELL DYN 4000, 0.15-0.35; GEN-S, 0.20-0.37; SE 9500 RET 0.05-0.21; VEGA RETIC: 0.06-0.23). The imprecision, obtained by 1-way analysis of variance on duplicates, was satisfactory for clinical use for all methods (coefficient of variation, 7.6%-20.5% in healthy subjects), although it was higher than the analytic goal based on biologic variability within subjects. The comparison of different methods shows that agreement is good only between SE 9500 RET CELL DYN 4000, and VEGA RETIC (r2 = 0.72-0.78). The study of diagnostic performance in distinguishing aplasia from early bone marrow recovery shows slightly different results (area under the curve from 0.70 for ADVIA 120 to 0.96 for SE 9500 RET). Even with slight differences, the fluorescence-based methods seem to be more robust than other methods for IRF measurement.
Article
Full-text available
This review addresses the pathophysiology and treatment of hemorrhagic shock - a condition produced by rapid and significant loss of intravascular volume, which may lead sequentially to hemodynamic instability, decreases in oxygen delivery, decreased tissue perfusion, cellular hypoxia, organ damage, and death. Hemorrhagic shock can be rapidly fatal. The primary goals are to stop the bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated severity of hemorrhage. It now appears that patients with moderate hypotension from bleeding may benefit by delaying massive fluid resuscitation until they reach a definitive care facility. On the other hand, the use of intravenous fluids, crystalloids or colloids, and blood products can be life saving in those patients who are in severe hemorrhagic shock. The optimal method of resuscitation has not been clearly established. A hemoglobin level of 7-8 g/dl appears to be an appropriate threshold for transfusion in critically ill patients with no evidence of tissue hypoxia. However, maintaining a higher hemoglobin level of 10 g/dl is a reasonable goal in actively bleeding patients, the elderly, or individuals who are at risk for myocardial infarction. Moreover, hemoglobin concentration should not be the only therapeutic guide in actively bleeding patients. Instead, therapy should be aimed at restoring intravascular volume and adequate hemodynamic parameters.
Article
Guidelines The British Journal of Haematology is the leading journal devoted to the scientific and clinical aspects of haematology. The journal publishes original research papers in clinical, laboratory and experimental haematology, state-of-the art reviews, invited commentary and debate on timely topics, letters and announcements. British Journal of Haematology is the official journal of the British Society of Haematology (BSH). Members of BSH receive the journal as a member ship benefit! The British Journal of Haematology frequently publishes Guidelines, keeping clinicians and staff in the field abreast of the latest recommendations, developments, and protocols. This virtual issue culls together all Guideline articles published in BJH since 2000, creating one convenient point of access for those seeking this valuable information.
Article
To establish the benefits of immature reticulocyte fraction (IRF) measurement using an automated hematology cells analyzer over absolute neutrophil count (ANC) in predicting bone marrow recovery post induction chemotherapy. A prospective observational study was carried out in the Departments of Pathology, Medicine, and Pediatrics, Universiti Kebangsaan Malaysia, Medical Center (UKMMC), Kuala Lumpur, Malaysia during a period of 19 months from April 2009 to December 2010 to assess the bone marrow recovery in patients with acute leukemia. A total of 22 patients in remission induction phases were enrolled in this study. The blood specimens were collected from day zero after chemotherapy, and every 3 days until patients recovered hematologically. All blood samples were measured for ANC and IRF using an automated hematology analyzer (Beckman-Coulter LH750). The percentage of patients showing IRF recovery earlier than ANC recovery was 63.6% (14 out of 22 patients). There was a significant difference in the mean number of days for IRF recovery as compared with ANC recovery (14.05 and 17.18 days), p=0.005. This study proved that IRF was more useful in predicting bone marrow recovery in a patient with acute leukemia post induction chemotherapy compared with ANC. The IRF is not affected by infection, is easily measured, and inexpensive; thus, it is a reliable parameter to evaluate bone marrow reconstitution.
Article
Polychromatophilic erythrocytes on Wright-stained blood smears represent young reticulocytes. Ratios of polychromatophilic cells to total reticulocyte counts have been used to estimate marrow response to erythropoietin stimulation. These ratios, however, require both accurate counts of polychromatophilic cells on Wright-stained blood smears and reticulocytes on supravitally stained blood smears. Data from this study indicated that reticulocytes of Heilmeyer groups I, II, and III best represent polychromatophilic cells. Group III reticulocytes, however, were found in normal circulation and were difficult to distinguish from group IV reticulocytes. Groups I and II were not found in normal circulation and were easily identified on routine reticulocyte preparations. The term "shift reticulocyte" is proposed for reticulocytes of groups I and II only. The present study suggests that the "shift reticulocyte count," expressed as percent of 100 reticulocytes, is a more useful indicator of marrow response to anemia than total reticulocyte counts.